https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Multidrug-resistant tuberculosis. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-1186-s40249-024-01230-3-5696923f/ https://globalinfectiousdisease.com/research/articles/10-1186-s40249-024-01230-3-5696923f/ Fri, 16 Aug 2024 00:00:00 GMT HIV-TB co-infection represents a major global public health challenge. The findings suggest that improved diagnostic and treatment strategies, strengthened healthcare infrastructure, increased access to quality care, and enhanced public health education are needed to address this co-infection. Tuberculosis AIDS Multidrug-resistant tuberculosis Antimicrobial resistance Diagnostics Treatment Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1186-s12879-021-06666-8-a4b3500e/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-021-06666-8-a4b3500e/ Fri, 17 Sep 2021 00:00:00 GMT Drug-resistant tuberculosis remains a major public health concern worldwide. The findings suggest bedaquiline has the potential to improve outcomes among drug-resistant tuberculosis cases. Tuberculosis Multidrug-resistant tuberculosis Treatment Antimicrobial resistance Systematic review https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaa621-ac7175ec/ https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaa621-ac7175ec/ Fri, 30 Oct 2020 00:00:00 GMT The findings suggest that streptomycin and amikacin should be preferred over kanamycin or capreomycin when drug susceptibility testing supports their use, potentially improving treatment success rates for MDR-TB patients worldwide. Tuberculosis Multidrug-resistant tuberculosis Treatment Antimicrobial resistance Meta-analysis https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2016-08-024-0ba80954/ https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2016-08-024-0ba80954/ Wed, 01 Mar 2017 00:00:00 GMT Addressing resistant tuberculosis strains represents a critical global health objective due to the severe financial burdens, adverse drug effects, and suboptimal recovery rates associated with conventional management approaches. Tuberculosis Multidrug-resistant tuberculosis Transmission dynamics Antimicrobial resistance Treatment Health policy Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2017-01-031-ce50428a/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2017-01-031-ce50428a/ Wed, 01 Mar 2017 00:00:00 GMT The article is relevant to TB control planning because it examines when resistant TB might become dominant and which transmission and treatment-related factors may matter in that scenario. It is mainly a strategic and theoretical contribution rather than an empirical report. Tuberculosis Multidrug-resistant tuberculosis Transmission dynamics Antimicrobial resistance Treatment Mathematical modelling